Patents Assigned to Binyarco, LLC
  • Method and device for packing a body cavity and delivering a medicament to a subject
    Patent number: 11083634
    Abstract: A medical packing device for use within a body cavity of a subject is provided. The medical packing device comprises an absorbent member having at least a first major side surface and at least one depression that is formed in the first major side surface and has a predetermined shape and volume. The at least one depression is defined by a continuous perimeter wall that is formed in the first major side surface and forms a reservoir capable of receiving and retaining a volume of a medicament therein.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: August 10, 2021
    Assignee: BINYARCO LLC
    Inventors: Jeffrey E. Binder, Arthur L. Clements, III, Gregory Weisberg, Paul L. Erickson, Stephanie A. Harrington
  • Composition and method for treating nosebleeds
    Patent number: 9248186
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: February 2, 2016
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder
  • COMPOSITION AND METHOD FOR TREATING NOSEBLEEDS
    Publication number: 20130052251
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Application
    Filed: October 30, 2012
    Publication date: February 28, 2013
    Applicant: BINYARCO, LLC
    Inventor: BINYARCO, LLC
  • Composition and method for treating nosebleeds
    Patent number: 8304402
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: November 6, 2012
    Assignee: Binyarco, LLC
    Inventor: Jeffrey E. Binder
  • Epistaxis treatment device
    Patent number: D868251
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: November 26, 2019
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder
  • Epistaxis treatment device
    Patent number: D945614
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 8, 2022
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder